Nitisinone and Erdafitinib: Interaction Details

Brand names
Erdafitinib
Balversa
Nitisinone
OrfadinNityrHarliku
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Nitisinone

Brand names
  • Orfadin
  • Nityr
  • Harliku

What Happens When You Take Nitisinone With Erdafitinib

What can happen when they are taken together (rated Major)

Increased erdafitinib exposure

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Erdafitinib is by , so giving it together with a moderate CYP2C9 can raise erdafitinib and heighten the risk of toxicity related to erdafitinib. During erdafitinib therapy, alternatives that are not moderate CYP2C9 should be considered.

When the combination cannot be avoided, patients should be watched closely for adverse events, and dose adjustments may be warranted based on what is observed. Once the moderate CYP2C9 inhibitor is stopped, the erdafitinib dose may be raised provided there is no drug-related toxicity.1

The Nitisinone and Erdafitinib Interaction, Explained

Nitisinone can raise the amount of erdafitinib in your body. Your body uses an enzyme called to break down erdafitinib, and nitisinone is thought to slow that enzyme down. That means erdafitinib can build up, which may make side effects more likely. Erdafitinib side effects can include mouth sores, dry mouth or eyes, nail and skin changes, high phosphate levels, and eye problems.

Please keep taking both medicines as prescribed. Talk with your pharmacist or doctor, who may choose a different option or watch you more closely. Your care team may also adjust and individualize your erdafitinib dose, and they can manage this combination safely.

Erdafitinib ( ) with nitisinone (moderate CYP2C9 ): expect increased erdafitinib exposure and a higher risk of dose-related toxicity.

  • Mechanism: of CYP2C9-mediated erdafitinib (probable).
  • Severity/evidence: major; evidence rated probable; onset unspecified.
  • Management: consider alternatives that are not moderate CYP2C9 . If is unavoidable, monitor closely for adverse events (e.g., hyperphosphatemia, ocular and dermatologic or nail toxicity, stomatitis) and consider dose modification.
  • If nitisinone is discontinued, erdafitinib may be increased again in the absence of drug-related toxicity.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Nitisinone and Erdafitinib Interact

The likely mechanism

of -mediated erdafitinib

In short: Nitisinone slows CYP2C9, an enzyme that breaks down erdafitinib, so erdafitinib can build up in the body.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When One Drug Raises Another’s Level”, one chapter of our one-minute explainer. See how it works 

How to Manage the Nitisinone and Erdafitinib Interaction

Your care team can manage this combination in a few ways.

  • They may look for an alternative that does not slow the enzyme.
  • If both medicines are needed, they may monitor you more closely for erdafitinib side effects and adjust and individualize your erdafitinib dose.
  • If nitisinone is later stopped, they may increase your erdafitinib dose again, provided you are not having side effects.

Keep taking both as prescribed and do not change doses on your own. Tell your pharmacist or prescriber about any new or worsening side effects, and check with them before starting or stopping any medicine.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Nitisinone or Erdafitinib need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: BALVERSA oral tablets, erdafitinib oral tablets

    When erdafitinib was given together with fluconazole (a moderate of and ), its mean and (inf) ratios rose by 121% and 148%, respectively, relative to erdafitinib given alone.1

Nitisinone and Erdafitinib: Common Questions

How serious is the Nitisinone and Erdafitinib interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Nitisinone and Erdafitinib interaction managed?

Your care team can manage this combination in a few ways. They may look for an alternative that does not slow the enzyme. If both medicines are needed, they may monitor you more closely for erdafitinib side effects and adjust and individualize your erdafitinib dose. If nitisinone is later stopped, they may increase your erdafitinib dose again, provided you are not having side effects. Keep… Management is individual — always follow your own care team's guidance.

Does taking Nitisinone and Erdafitinib at different times of day help?

No. Taking them at different times of day does not prevent this one. Nitisinone slows , an enzyme that breaks down erdafitinib, so erdafitinib can build up in the body. That change lasts while nitisinone is being taken and can continue for a while after the last dose.

Your pharmacist or prescriber can tell you how they will manage it.

Is there an alternative to taking Nitisinone with Erdafitinib?

They may look for an alternative that does not slow the enzyme.

Only your prescriber can decide whether a change fits you, so talk with them before changing either medicine.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Ask About the Nitisinone and Erdafitinib Interaction

Ask in your own words about taking Nitisinone and Erdafitinib together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: BALVERSA(R) oral tablets, erdafitinib oral tablets. Janssen Products LP (per FDA), Horsham, PA, 2024. DailyMed
Was this write-up helpful?

Other Serious Interactions of Nitisinone and Erdafitinib

Also serious with Erdafitinib

Also serious with Nitisinone

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Erdafitinib

With Nitisinone

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven. This interaction.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.